It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Many Gram-negative bacteria use CdiA effector proteins to inhibit the growth of neighboring competitors. CdiA transfers its toxic CdiA-CT region into the periplasm of target cells, where it is released through proteolytic cleavage. The N-terminal cytoplasm-entry domain of the CdiA-CT then mediates translocation across the inner membrane to deliver the C-terminal toxin domain into the cytosol. Here, we show that proteolysis not only liberates the CdiA-CT for delivery, but is also required to activate the entry domain for membrane translocation. Translocation function depends on precise cleavage after a conserved VENN peptide sequence, and the processed ∆VENN entry domain exhibits distinct biophysical and thermodynamic properties. By contrast, imprecisely processed CdiA-CT fragments do not undergo this transition and fail to translocate to the cytoplasm. These findings suggest that CdiA-CT processing induces a critical structural switch that converts the entry domain into a membrane-translocation competent conformation.
Contact-dependent growth inhibition (CDI) is an important mechanism of bacterial competition. Here, Bartelli et al. show that proteolytic processing of a CDI toxin induces a conformational switch required for translocation into target bacteria.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details











1 University of California, Department of Chemistry and Biochemistry, Santa Barbara, USA (GRID:grid.133342.4) (ISNI:0000 0004 1936 9676)
2 Argonne National Laboratory, Midwest Center for Structural Genomics, Lemont, USA (GRID:grid.187073.a) (ISNI:0000 0001 1939 4845); University of Chicago, Center for Structural Genomics of Infectious Diseases, Chicago, USA (GRID:grid.170205.1) (ISNI:0000 0004 1936 7822); Argonne National Laboratory, Structural Biology Center, X-ray Science Division, Lemont, USA (GRID:grid.187073.a) (ISNI:0000 0001 1939 4845)
3 University of California, Biomolecular Science and Engineering Program, Santa Barbara, USA (GRID:grid.133342.4) (ISNI:0000 0004 1936 9676)
4 University of California, Department of Molecular, Cellular and Developmental Biology, Santa Barbara, USA (GRID:grid.133342.4) (ISNI:0000 0004 1936 9676)
5 University of California, Department of Molecular Biology & Biochemistry, Irvine, USA (GRID:grid.266093.8) (ISNI:0000 0001 0668 7243)
6 Argonne National Laboratory, Midwest Center for Structural Genomics, Lemont, USA (GRID:grid.187073.a) (ISNI:0000 0001 1939 4845)
7 University of California, Department of Molecular Biology & Biochemistry, Irvine, USA (GRID:grid.266093.8) (ISNI:0000 0001 0668 7243); University of California, Pharmaceutical Sciences, Irvine, USA (GRID:grid.266093.8) (ISNI:0000 0001 0668 7243)
8 University of California, Biomolecular Science and Engineering Program, Santa Barbara, USA (GRID:grid.133342.4) (ISNI:0000 0004 1936 9676); University of California, Department of Molecular, Cellular and Developmental Biology, Santa Barbara, USA (GRID:grid.133342.4) (ISNI:0000 0004 1936 9676)
9 Argonne National Laboratory, Midwest Center for Structural Genomics, Lemont, USA (GRID:grid.187073.a) (ISNI:0000 0001 1939 4845); University of Chicago, Center for Structural Genomics of Infectious Diseases, Chicago, USA (GRID:grid.170205.1) (ISNI:0000 0004 1936 7822); Argonne National Laboratory, Structural Biology Center, X-ray Science Division, Lemont, USA (GRID:grid.187073.a) (ISNI:0000 0001 1939 4845); University of Chicago, Department of Biochemistry and Molecular Biology, Chicago, USA (GRID:grid.170205.1) (ISNI:0000 0004 1936 7822)
10 University of California, Department of Chemistry and Biochemistry, Santa Barbara, USA (GRID:grid.133342.4) (ISNI:0000 0004 1936 9676); University of California, Biomolecular Science and Engineering Program, Santa Barbara, USA (GRID:grid.133342.4) (ISNI:0000 0004 1936 9676); University of California, Department of Molecular, Cellular and Developmental Biology, Santa Barbara, USA (GRID:grid.133342.4) (ISNI:0000 0004 1936 9676)